Clinical trial
Use of Erythromycin in Mustard-Induced Bronchiolitis
NCT00367419 · Baqiyatallah Medical Sciences University, Other · Completed
Key facts
| NCT number | NCT00367419 |
|---|---|
| Title | Use of Erythromycin in Mustard-Induced Bronchiolitis |
| Official title | Low-Dose Long-Term Prescription of Erythromycin in Mustard-Induced Bronchiolitis Obliterans |
| Lead sponsor | Baqiyatallah Medical Sciences University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bronchiolitis Obliterans, Acute Obliterating Bronchiolitis |
| Intervention type | Drug |
| Interventions | Erythromycin |
| First posted | Aug 22, 2006 |
| Last update posted | Nov 5, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: